Find in Library

5610224 THE USE OF LUSPATERCEPT IN PATIENTS WITH β -THALASSAEMIA AND MULTIPLE SYSTEMIC COMPLICATIONS INCREASES HEMOGLOBIN LEVEL, DECREASES TRANSFUSION BURDEN, AND IS UNAFFECTED BY COMPLICATIONS. SINGLE THALASSEMIA AND SICKLE CELL DEPARTEMENT’S EXPERIENCE.

oleh: K.M. Manganas, K.A. Kotsiafti, X.A. Xydaki, D.P. Patsourakos, K.A. Aggeli, S.C. Savvidis, K.I. Koskinas, S.D. Delicou